 |
 |

Dyslipoproteinemia in Patients With Xanthelasma
Xavier Pintó, MD;
Miquel Ribera, MD;
Concepción Fiol, MD
Hospital de Bellvitge Principes de España University of Barcelona Barcelona, Spain
Arch Dermatol. 1989;125(9):1281-1282.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
To the Editor.—
We have read with interest the article by Gómez et al1 about the relationship between lipid metabolism abnormalities and xanthelasma. In their study, the lipoprotein profile found in subjects with xanthelasma does not explain their predisposition to the dermal lipid deposits, and, curiously, lower levels of the atherogenic apoprotein B were observed with respect to a control group.
We have actually studied lipid metabolism in 96 subjects with xanthelasma (age, 52.3 ± 11.4 years; 25 male, 71 female) and in 104 healthy control subjects (age, 50.7 ± 10.6 years; 56 male, 48 female). The design of our study differs mainly in the selection of control subjects that were included on the basis of the absence of xanthelasma, but not of plasma lipid values as stated by Gómez. As can be seen in the Table, subjects with xanthelasma of both sexes had total and low-density lipoprotein cholesterol and
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|